InsiderClue
← All stocks

Compass Therapeutics, Inc.

CMPX Net buying
CIK 0001738021 #3229 in the set updated 18 Sep 2026
Bought (120 mo)
$60.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$11.56M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$11.56M
7 of 7 sales
Net
+$49.05M
+$49.05M against sales at will

By person

10 insiders · 55 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GORDON CARL L
Director
$27.93M (10)
$5.68M (1)
+$22.26M
12,714,404
7.06%
$26.83M
+45.2%
ORBIMED ADVISORS LLC entity
Director
$27.93M (10)
$5.68M (1)
+$22.26M
12,714,404
7.06%
$26.83M
+45.2%
Schuetz Thomas J.
CHIEF EXECUTIVE OFFICER
$1.66M (23)
—
+$1.66M
6,603,336
3.67%
$13.93M
+49.1%
Ferneau Philip
Director
$1.57M (2)
—
+$1.57M
400,280
0.2223%
$844.59K
+364.3%
Sunderland Julie
Director
$1.45M (1)
—
+$1.45M
2,502,025
1.39%
$5.28M
+13.1%
Bisker-Leib Vered
CHIEF EXECUTIVE OFFICER
—
$200.69K (5)
−$200.69K
3,124,426
1.73%
$6.59M
+487.7%
Anderman Jonathan
General Counsel
$30.80K (1)
—
+$30.80K
196,000
0.1088%
$413.56K
+19,500%
Lerner Neil
Chief Accounting Officer
$28.40K (1)
—
+$28.40K
397,500
0.2207%
$838.73K
+32.5%
Toledano Miranda Jayne
Director
—
—
—
1,791,549
0.9948%
$3.78M
—
Shin Barry
CFO
—
—
—
525,000
0.2915%
$1.11M
—

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
Schuetz Thomas J.
27 May 2025
CHIEF EXECUTIVE OFFICER
Buy
10,000
$2.11
$21.10K
Lerner Neil
7 Apr 2025
CHIEF ACCOUNTING OFFICER
Buy
20,000
$1.42
$28.40K
Anderman Jonathan
7 Apr 2025
Gen Counsel & Corporate Sec
Buy
20,000
$1.54
$30.80K
Schuetz Thomas J.
10 Mar 2023
CHIEF EXECUTIVE OFFICER
Buy
10,000
$3.37
$33.70K
Schuetz Thomas J.
27 Feb 2023
CHIEF EXECUTIVE OFFICER
Buy
20,000
$3.98
$79.60K
Schuetz Thomas J.
15 Feb 2023
CHIEF EXECUTIVE OFFICER
Buy
20,000
$3.86
$77.20K
Schuetz Thomas J.
31 Jan 2023
CHIEF EXECUTIVE OFFICER
Buy
20,000
$4.05
$81.00K
Schuetz Thomas J.
24 Jan 2023
CHIEF EXECUTIVE OFFICER
Buy
20,000
$4.19
$83.80K
GORDON CARL L
8 Nov 2022
Director
Buy indirect
402,000
$3.21
$1.29M
ORBIMED ADVISORS LLC
8 Nov 2022
Director
Buy indirect
402,000
$3.21
$1.29M
Schuetz Thomas J.
28 Sep 2022
CHIEF EXECUTIVE OFFICER
Buy
10,000
$2.32
$23.20K
Schuetz Thomas J.
26 Sep 2022
CHIEF EXECUTIVE OFFICER
Buy
15,000
$2.27
$34.05K
Schuetz Thomas J.
7 Sep 2022
CHIEF EXECUTIVE OFFICER
Buy
15,000
$3.03
$45.45K
Schuetz Thomas J.
1 Sep 2022
CHIEF EXECUTIVE OFFICER
Buy
15,000
$2.83
$42.45K
Schuetz Thomas J.
17 Aug 2022
CHIEF EXECUTIVE OFFICER
Buy
15,000
$3.05
$45.75K
Schuetz Thomas J.
10 Aug 2022
CHIEF EXECUTIVE OFFICER
Buy
15,000
$2.64
$39.60K
Schuetz Thomas J.
1 Aug 2022
CHIEF EXECUTIVE OFFICER
Buy
15,000
$2.58
$38.70K
Schuetz Thomas J.
21 Jun 2022
CHIEF EXECUTIVE OFFICER
Buy
20,000
$2.80
$56.00K
Schuetz Thomas J.
16 Jun 2022
CHIEF EXECUTIVE OFFICER
Buy
20,000
$2.34
$46.80K
Schuetz Thomas J.
13 Jun 2022
CHIEF EXECUTIVE OFFICER
Buy
30,000
$2.29
$68.70K
Schuetz Thomas J.
6 Jun 2022
CHIEF EXECUTIVE OFFICER
Buy
30,000
$2.83
$84.90K
Schuetz Thomas J.
1 Jun 2022
CHIEF EXECUTIVE OFFICER
Buy
20,000
$3.03
$60.60K
Schuetz Thomas J.
26 May 2022
CHIEF EXECUTIVE OFFICER
Buy
20,000
$3.04
$60.80K
Schuetz Thomas J.
23 May 2022
CHIEF EXECUTIVE OFFICER
Buy
18,355
$2.72
$49.93K
Schuetz Thomas J.
17 May 2022
CHIEF EXECUTIVE OFFICER
Buy
20,215
$2.47
$49.93K
ORBIMED ADVISORS LLC
13 May 2022
Director
Buy indirect
30,722
$2.49
$76.50K
GORDON CARL L
13 May 2022
Director
Buy indirect
30,722
$2.49
$76.50K
ORBIMED ADVISORS LLC
12 May 2022
Director
Buy indirect
97,094
$2.35
$228.17K
GORDON CARL L
12 May 2022
Director
Buy indirect
97,094
$2.35
$228.17K
ORBIMED ADVISORS LLC
11 May 2022
Director
Buy indirect
64,700
$1.79
$115.81K
GORDON CARL L
11 May 2022
Director
Buy indirect
64,700
$1.79
$115.81K
Schuetz Thomas J.
10 May 2022
CHIEF EXECUTIVE OFFICER
Buy
27,836
$1.80
$50.10K
GORDON CARL L
10 May 2022
Director
Buy indirect
24,447
$1.60
$39.12K
ORBIMED ADVISORS LLC
10 May 2022
Director
Buy indirect
24,447
$1.60
$39.12K
GORDON CARL L
9 May 2022
Director
Buy indirect
90,712
$1.56
$141.51K
ORBIMED ADVISORS LLC
9 May 2022
Director
Buy indirect
90,712
$1.56
$141.51K
GORDON CARL L
6 May 2022
Director
Buy indirect
10,200
$1.63
$16.63K
ORBIMED ADVISORS LLC
6 May 2022
Director
Buy indirect
10,200
$1.63
$16.63K
ORBIMED ADVISORS LLC
4 Nov 2021
Director
Buy indirect
3,571,428
$3.50
$12.50M
ORBIMED ADVISORS LLC
4 Nov 2021
Director
Buy indirect
1,785,715
$3.50
$6.25M
GORDON CARL L
4 Nov 2021
Director
Buy indirect
3,571,428
$3.50
$12.50M
GORDON CARL L
4 Nov 2021
Director
Buy indirect
1,785,715
$3.50
$6.25M
ORBIMED ADVISORS LLC
19 Jun 2020
Director
Buy
1,455,132
$5.00
$7.28M
GORDON CARL L
19 Jun 2020
Director
Buy indirect
1,455,132
$5.00
$7.28M
Ferneau Philip
19 Jun 2020
Director
Buy indirect
250,000
$5.00
$1.25M
Ferneau Philip
19 Jun 2020
Director
Buy indirect
64,066
$5.00
$320.33K
Schuetz Thomas J.
19 Jun 2020
Chief Executive Officer
Buy
97,431
$5.00
$487.16K
Sunderland Julie
19 Jun 2020
Director
Buy indirect
289,118
$5.00
$1.45M
Show all 55 transactions →

What was left out

Form 4 filings counted 112
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 7,739,324
Sales filed before the plan box existed 5
History held since 23 Jun 2020